A “micro-tap” for treating glaucoma

Share via AddThis
Posted on March 26, 2013

A tiny, EPFL-designed implantable device that can be positioned within the eye and controlled remotely may well revolutionize the treatment of glaucoma. The device should be through testing this year and on its way to the market in 2014 via Rheon Medical, an EPFL spin-off.

Glaucoma is the second leading cause of blindness globally, after cataracts. It is characterized by the presence of too much liquid between the cornea and the iris. This leads to a build-up of pressure within the eye, a situation that can destroy the optic nerve if it is not handled correctly.

Read more at: EPFL



39,045 science & technology articles

Categories

Our Articles (see all)

General News

Follow us

Facebook   Twitter   Pinterest   StumbleUpon   Plurk
Google+   Tumblr   Delicious   RSS   Newsletter via Email

Featured Video (see all)


Sunglasses on demand
Apart from their style, sunglasses have changed very little in the last few decades. Photochromic lenses that change…

Featured Image (see all)


Solar Eclipse From the International Space Station
Expedition 43 Flight Engineer Samantha Cristoforetti took a series of photographs of the March 20, 2015 solar eclipse…